# A Study to Evaluate the Bioequivalence of DA-5230 Compared to DA-5230-R

> **NCT07513649** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Dong-A ST Co., Ltd.** · enrollment: 60 (estimated)

## Conditions studied

- Healthy Adult Participants

## Interventions

- **DRUG:** DA-5230
- **DRUG:** DA-5230-R

## Key facts

- **NCT ID:** NCT07513649
- **Lead sponsor:** Dong-A ST Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2026-05
- **Final completion:** 2026-05
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07513649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07513649, "A Study to Evaluate the Bioequivalence of DA-5230 Compared to DA-5230-R". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07513649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*